Advances in elderly patients with newly diagnosed multiple myeloma from the 19th European Hematology Association Annual Congress / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
;
(12): 390-392, 2014.
Artículo
en Chino
| WPRIM
| ID: wpr-475045
ABSTRACT
As the introduction of novel agents,the median overall survival of elderly newly diagnosed multiple myeloma patients has increased roughly from 30 to 60 months.But patients with high risk prognostic features still have a poor clinical outcome.This paper which combined the 19th annual congress of the European Hematology Association (EHA) reviews the advances in elderly patients with newly diagnosed multiple myeloma,including standard of care,the way to treatment and prognostic factors.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Estudio diagnóstico
/
Estudio pronóstico
Idioma:
Chino
Revista:
Journal of Leukemia & Lymphoma
Año:
2014
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS